Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.41
+0.15 (0.87%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
-0.34 (-1.95%)
After-hours: Dec 5, 2025, 7:48 PM EST
Monte Rosa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,134 | 426 | 283 | 368 | 950 | - | |
| Market Cap Growth | 122.06% | 50.74% | -23.21% | -61.22% | - | - | |
| Enterprise Value | 783 | 228 | 151 | 142 | 583 | - | |
| Last Close Price | 17.41 | 6.94 | 5.65 | 7.61 | 20.42 | - | |
| PS Ratio | 7.88 | 5.64 | - | - | - | - | |
| PB Ratio | 4.38 | 1.91 | 1.58 | 1.36 | 2.73 | - | |
| P/TBV Ratio | 4.61 | 1.91 | 1.58 | 1.36 | 2.73 | - | |
| P/FCF Ratio | 7.82 | 11.22 | - | - | - | - | |
| P/OCF Ratio | 7.60 | 10.15 | - | - | - | - | |
| EV/Sales Ratio | 4.31 | 3.01 | - | - | - | - | |
| EV/FCF Ratio | 5.40 | 6.00 | - | - | - | - | |
| Debt / Equity Ratio | 0.16 | 0.19 | 0.26 | 0.17 | - | - | |
| Debt / FCF Ratio | 0.28 | 1.12 | - | - | - | - | |
| Asset Turnover | 0.47 | 0.20 | - | - | - | - | |
| Quick Ratio | 6.45 | 2.37 | 5.00 | 10.58 | 20.80 | 1.43 | |
| Current Ratio | 6.54 | 2.40 | 5.07 | 10.79 | 20.96 | 1.49 | |
| Return on Equity (ROE) | 9.28% | -36.15% | -60.07% | -35.06% | -40.35% | -277.72% | |
| Return on Assets (ROA) | 1.37% | -13.66% | -27.72% | -19.82% | -21.92% | -57.90% | |
| Return on Capital (ROIC) | 1.99% | -20.65% | -32.95% | -21.09% | -24.85% | -131.69% | |
| Return on Capital Employed (ROCE) | 2.10% | -28.80% | -55.70% | -35.50% | -20.80% | -139.30% | |
| Earnings Yield | 1.85% | -17.05% | -47.85% | -29.46% | -7.79% | - | |
| FCF Yield | 12.79% | 8.91% | -22.22% | -28.61% | -7.28% | - | |
| Buyback Yield / Dilution | -22.34% | -43.80% | -8.83% | -88.91% | -1548.09% | -7.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.